Company / Revenue per Share
Bioventus Inc. Revenue per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$9.07
FY2025
5-year range
$7.48 / $11.26
FY2021-FY2025
Trend
-2.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has declined for 3 consecutive years, from $11.26 in FY2022 to $9.07 in FY2025.
Based on SEC 10-K filings.
9.07 in FY2025 with a 3-year CAGR of -7.0%.
Declined from $9.48 to $9.07 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -7.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Bioventus Inc.'s revenue per share has declined for 3 consecutive years.
- In FY2025, revenue per share decreased 2.9% year-over-year.
- Peak revenue per share was recorded in FY2022.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.07 | -2.9% |
| FY2024 | $9.34 | -1.5% |
| FY2023 | $9.48 | -15.9% |
| FY2022 | $11.26 | +50.6% |
| FY2021 | $7.48 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026